Grand Pharmaceutical Group Ltd

00512

Company Profile

  • Business description

    Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.

  • Contact

    99 Queen's Road Central
    Units 3302, 33rd Floor, The Center
    Hong Kong
    HKG

    https://www.grandpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    12,614

Stocks News & Analysis

stocks

ASX biotech expands diagnostics portfolio after FDA approval

FDA nod adds another growth driver for ASX share.
stocks

Is it time to bail on Australian stocks?

Is your home bias costing your portfolio better returns?
stocks

ASX share undervalued despite margin woes

Short term margin pressure yet shares remain undervalued on improved outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,849.3074.60-0.84%
CAC 408,090.2827.50-0.34%
DAX 4025,402.2838.53-0.15%
Dow JONES (US)52,093.11328.09-0.63%
FTSE 10010,658.1339.44-0.37%
HKSE24,667.24250.36-1.00%
NASDAQ25,981.57204.84-0.78%
Nikkei 22563,484.108.89-0.01%
NZX 50 Index13,549.4765.250.48%
S&P 5007,585.7334.25-0.45%
S&P/ASX 2008,672.5077.40-0.88%
SSE Composite Index3,864.2821.05-0.54%

Market Movers